Publication | Open Access
Long‐term outcome of re‐irradiation for recurrent or second primary head and neck cancer: A multi‐institutional study of AIRO—Head and Neck working group
22
Citations
21
References
2019
Year
Our data reinforce the survival benefit of Re-RT for selected patients with RSPHNC. MIRI RPA was not validated in our population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1